Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model

Nonalcoholic fatty liver disease (NAFLD), the most common liver disease, has become a silent worldwide pandemic. The incidence of NAFLD correlates with the rise in obesity, type 2 diabetes, and metabolic syndrome. A hallmark featureof NAFLD is excessive hepatic fat accumulation or steatosis, due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzman, Stephania, Dragan, Magdalena, Kwon, Hyokjoon, de Oliveira, Vanessa, Rao, Shivani, Bhatt, Vrushank, Kalemba, Katarzyna M., Shah, Ankit, Rustgi, Vinod K., Wang, He, Bech, Paul R., Abbara, Ali, Izzi-Engbeaya, Chioma, Manousou, Pinelopi, Guo, Jessie Y., Guo, Grace L., Radovick, Sally, Dhillo, Waljit S., Wondisford, Fredric E., Babwah, Andy V., Bhattacharya, Moshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106350/
https://www.ncbi.nlm.nih.gov/pubmed/35349482
http://dx.doi.org/10.1172/JCI145889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106350/
https://www.ncbi.nlm.nih.gov/pubmed/35349482
http://dx.doi.org/10.1172/JCI145889

Ejemplares similares